Data from the Phase III REVISIT and ASSEMBLE studies showed that Pfizer’s investigational antibiotic combination aztreonam-avibactam could safely cure infections caused by Gram-negative bacteria, the company announced Thursday.
Tag Archive for: drug-resistant Gram-negative bacterial infections
Shares of Spero Therapeutics soared in premarket trading following GlaxoSmithKline’s announcement that it will license the company’s late-stage antibiotic asset, tebipenem HBr, a potential treatment for complicated urinary tract infections.
